Involvement of retinoid X receptor α in coenzyme Q metabolism

Journal of Molecular Biology

Volumn 326, Issue 3, 2003, Pages 795-803

  Bentinger, Magnus ^a   Turunen, Mikael ^a   Zhang, Xiao Xue ^b   Yvonne Wan, Yu Jui ^b   Dallner, Gustav ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Cholesterol; Coenzyme Q; Peroxisomal proliferators; PPAR ; RXR

Indexed keywords

CHOLESTEROL; DOLICHOL; LIPID; MEVALONIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; RETINOID X RECEPTOR; RETINOID X RECEPTOR ALPHA; UBIQUINONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL LIVER LEVEL; COLD EXPOSURE; CONTROLLED STUDY; KIDNEY; LIPID METABOLISM; LIPOGENESIS; LIVER; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; REGULATORY MECHANISM;

EID: 0037459102     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(02)01447-X     Document Type: Article

References (38)

1. Dallner G., Sindelar P. Regulation of ubiquinone metabolism. Free Radic. Biol. Med. 29:2000;285-294.
2. + transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone). Proc. Natl Acad. Sci. USA. 98:2001;1416-1421.
3. Scorrano L., Petronilli V., Di Lisa F., Bernardi P. Commitment to apoptosis by GD3 ganglioside depends on opening of the mitochondrial permeability transition pore. J. Biol. Chem. 274:1999;22581-22585.
4. Ernster L., Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta. 1271:1995;195-204.
5. Ernster L. Lipid peroxidation in biological membranes: mechanisms and implications. Yagi K. Active Oxygens, Lipid Peroxides, and Antioxidants. 1993;1-38 CRC Press, Boca Raton, FL.
6. Mashima R., Witting P.K., Stocker R. Oxidants and antioxidants in atherosclerosis. Curr. Opin. Lipidol. 12:2001;411-418.
7. Frei B., Kim M.C., Ames B.N. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc. Natl Acad. Sci. USA. 87:1990;4878-4883.
8. Kalén A., Appelkvist E.L., Dallner G. Age-related changes in the lipid composition of rat and human tissues. Lipids. 24:1989;579-584.
9. 10 (CoQ) to treat patients with cardiomyopathy and CoQ levels in blood and endomyocardial biopsies. Folkers K., Yamamura Y. Biomedical and Clinical Aspects of Coenzyme Q. vol. 4:1984;391-402 Elsevier, Amsterdam.
10. Eggens I., Elmberger P.G., Löw P. Polyisoprenoid, cholesterol and ubiquinone levels in human hepatocellular carcinomas. Br. J. Exp. Path. 70:1989;83-92.
11. Littarru G.P., Battino M., Folkers K. Clinical aspects of coenzyme Q: improvement of cellular bioenergetics or antioxidant protection? Cadenas E., Packer L. Handbook of Antioxidants. 1996;203-239 Marcel Decker, New York.
12. Guan Z.Z., Söderberg M., Sindelar P., Prusiner S.B., Kristensson K., Dallner G. Lipid composition in scrapie-infected mouse brain: prion infection increases the levels of dolichyl phosphate and ubiquinone. J. Neurochem. 66:1996;277-285.
13. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature. 343:1990;425-430.
14. Grünler J., Ericsson J., Dallner G. Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins. Biochim. Biophys. Acta. 1212:1994;259-277.
15. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science. 232:1986;34-47.
16. Andersson M., Elmberger P.G., Edlund C., Kristensson K., Dallner G. Rates of cholesterol, ubiquinone, dolichol and dolichyl-P biosynthesis in rat brain slices. FEBS Letters. 269:1990;15-18.
17. Åberg F., Zhang Y., Appelkvist E.L., Dallner G. Effect of clofibrate, phthalates and probucol on ubiquinone levels. Chem. Biol. Interact. 91:1994;1-14.
18. Turunen M., Peters J.M., Gonzalez F.J., Schedin S., Dallner G. Influence of peroxisome proliferator-activated receptor α on ubiquinone biosynthesis. J. Mol. Biol. 297:2000;607-614.
19. Laudet V., Gronemeyer H. The Nuclear Receptor Facts Book. 2002;248-272 Academic Press, San Diego.
20. Rastinejad F. Retinoid X receptor and its partners in the nuclear receptor family. Curr. Opin. Struct. Biol. 11:2001;33-38.
21. Wan Y.-J.Y., An D., Cai Y., Repa J.J., Chen H.-P., Flores M., et al. Hepatocyte-specific mutation establishes retinoid X receptor α as a heterodimeric integrator of multiple physiological processes in the liver. Mol. Cell. Biol. 20:2000;4436-4444.
22. Wan Y.-J.Y., An D., Lungo W., Fu P., Locker J., French S., Sucov H.M. Peroxisome proliferator-activated receptor α-mediated pathways are altered in hepatocyte-specific retinoid X receptor α-deficient mice. J. Biol. Chem. 275:2000;28285-28290.
23. Ericsson J., Appelkvist E.L., Thelin A., Chojnacki T., Dallner G. Isoprenoid biosynthesis in rat liver peroxisomes - characterization of cis-prenyltrasferase and squalene synthase. J. Biol. Chem. 267:1992;18707-18714.
24. Elmberger P.G., Kalén A., Appelkvist E.L., Dallner G. In vitro and in vivo synthesis of dolichol and other main mevalonate products in various organs of the rat. Eur. J. Biochem. 168:1987;1-11.
25. Aithal H.N., Joshi V.C., Ramasarma T. Effect of cold exposure on the metabolism of ubiquinone in the rat. Biochim. Biophys. Acta. 162:1968;66-72.
26. Marbois B.N., Xia Y.R., Lusis A.J., Clarke C.F. Ubiquinone biosynthesis in eukaryotic cells: tissue distribution of mRNA encoding 3,4-dihydroxy-5-polyprenylbenzoate methyltransferase in the rat and mapping of the COQ3 gene to mouse chromosome 4. Arch. Biochem. Biophys. 313:1994;83-88.
27. Vajo Z., King L.M., Jonassen T., Wilkin D.J., Ho N., Munnich A., et al. Conservation of Caenorhabditis elegans timing gene clk-1 from yeast to human: a gene required for ubiquinone biosynthesis with potential implications for aging. Mamm. Genome. 10:1999;1000-1004.
28. Dolle P., Fraulob V., Kastner P., Chambon P. Developmental expression of murine retinoid X receptor (RXR) genes. Mech. Dev. 45:1994;91-104.
29. Kephart D.D., Walfish P.G., DeLuca H., Butt T.R. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hyroxylase vitamin D response elements in yeast. Mol. Endocrinol. 10:1996;408-419.
30. Tu H., Okamoto A.Y., Shan B. FXR, a bile acid receptor and biological sensor. Trends Cardiovasc. Med. 10:2000;30-35.
31. Edwards P.A., Kast H.R., Anisfeld A.M. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J. Lipid Res. 43:2002;2-12.
32. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20:1999;649-688.
33. Fayard E., Schoonjans K., Auwerx J. Xol INXS: role of the liver X and the farnesol X receptors. Curr. Opin. Lipidol. 12:2001;113-120.
34. Hefco E., Krulich L., Illner P., Larsen P.R. Effect of acute exposure to cold on the activity of the hypothalamic-pituitary-thyroid system. Endocrinology. 97:1975;1185-1195.
35. Horrum M.A., Tobin R.B., Ecklund R.E. Thyroxin-induced changes in rat liver mitochondrial ubiquinone. Biochem. Biophys. Res. Commun. 138:1986;381-386.
36. Horwitz B.A. The effect of cold exposure on liver mitochondrial and peroxisomal distribution in the rat, hamster and bat. Comput. Biochem. Physiol. ser. A. 54:1976;45-48.
37. Keller R.K. The mechanism and regulation of dolichyl phosphate biosynthesis in rat liver. J. Biol. Chem. 261:1986;12053-12059.
38. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.